Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
Related Posts
Martinez C, Haw NJ, Rodriguez VJ, Kizer JR, Post WS, Wu KC, Lima JAC, Wise JM, Alcaide ML, Plankey M, Konkle-Parker D, Kozlova S, Fischl[...]
Lau CE, DiTullio DJ, Wilhalme H, Bowles L, Moore TB, De Oliveira SN. Prevalence of Viral Infections and Serious Complications in Pediatric Hematopoietic Stem Cell[...]
Amaru R, Prchal J, Ganz T, Zhang X, Paton D, Carrasco M, Mancilla E, Gordeuk VR. Increased Transferrin Concentrations Are Not Associated With Thrombosis in[...]